或继发微循环障碍破坏了胰腺间质细胞内的屏障防护作用 , 从而启动胰腺的自身消化机制 , 引发炎症。明确可引起药源性胰腺炎的药物包括：由于不同药物引起 AP 的机制不同, 即使同一药物对不同个体的致病过程和程度亦常有较大差异。目前 DAP 多为个例报道，因致病药物的类别和病人机体状况的差异, 不少人缺乏 AP 典型的腹痛

（AP）调节异常的结果。C3 肾小球病包括 C3 肾炎和致密物沉积病（DDD）。在补体介导 GN（C3 肾小球肾病）中，C3 染色明亮，Ig 染色通常阴性。然而... 例）C4d 染色痕量或 1+。至于感染后 GN，46%（6 例）的样本 C4d 染色阴性，提示 AP 途径不正常，54%（7 例）的样本阳性。（见图 1）图 1

of RhoA, Rac1 and AP-1 transcriptional activity. Taken together, our results

的前后(AP)径和椎板开门的角度。术前、术后1年通过MRI检查来评价脊髓压迫的严重程度。结果发现，椎管的前后径和椎板开门的角度虽在术后立即增加(均P

工作。K医院专家着重对甲状腺癌诊疗规范、碘-131治疗适应症、核素治疗剂量、辐射管理、核素病房设计等技术方面提出了问题，颜兵教授给予了详细解答。K医院专家对霍普...霍普医疗去越南开设这样的以甲状腺为特色专业的私立医院。最后，颜兵院长祝愿越南考察团中国之行愉快！儿童核素病房VIP核素房间碘-131残留量监测仪洗澡淋浴间五个

;核素内照射治疗-38131I治疗Grave’s病-39原理...疗效评价-52131I治疗自主高功能腺瘤-53 

, please click: http://www.genomeconference.org/pages/Abstract.aspxTop Poster

抗微生物药物治疗的正确疗程如何？预防性使用抗生素指南内容1. 最近的证据表明，AP 患者预防性使用抗生素并没有显著降低病死率或并发症发生率。因此，不再推荐对所有 AP 患者常规预防性使用抗生素（1A）。虽然早期的试验表明无菌性坏死的患者使用抗生素可能会预防感染性并发症，但后续的设计更好的试验

ligase），可以催化它的 15 个长链氨基酸受体肽（amino acid acceptor peptide, AP）受质中的赖氨酸（Lysine）生物素化（biotinylation）反应。所以，生物素化的 AP 即可和含萤光的共轭链酶亲和素（streptavidin）结合，如此便可观测到活神经细胞表面交互作用的萤光

trials and regulatory affairs
A special showcase of top 10 Chinese innovative device companies and top 5 selected US/EU device companies interested in China

。【报名回执】访问此链接填写报名回执（https://www.wjx.top/jq/80710449.aspx）【咨询请联系】QQ 号：2814500767邮箱

会议简介

According to Business Insights, an estimated $25bn worth of biologics will lose patent protection by 2016, creating a significant market opportunity for biosimilars. However, the reality is that biosimilar development is a risk-fraught activity that demands significant resources in R&D, manufacturing expertise, regulatory know-how, clinical-trial capabilities, and a high level of financial investment.

Biosimilar development is riddled with complexities, ranging from regulatory, to manufacturing to marketing, and is one of the most expensive propositions in the pharmaceutical industry. It is estimated that it costs between US$100-200 million to bring a biosimilar product to market. With so much at stake, biosimilars represent not only substantial growth but equally risk..

IBC’s 2nd Annual Biosimilars Asia 2011 Summit is the ONLY conference in Asia catering to this region’s specific queries. With unprecedented insights from leading innovators and biosimilar companies, you will network and learn how to strategically position your company to maximize your ROI. Biosimilars Asia 2011 is attended by key stakeholders in the region and beyond, enabling you to make informed strategic decisions.

Register Now

PAYMENT TERMS

Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry cut-off date, registration and payment must be received by the cut off date.

Payments by Singapore Dollars (S$)

Payments by RMB (CNY)

• Payment by telegraphic transfer in CNY must be made to:
  A/C Name:
  A/C No.: 720-031103-001
  Beneficiary Bank:
  Bank Address: No. 1000 Lujiazui Rind Road,
  Pudong, Shanghai 200120, P.R. China
  Bank Swift Code: HSBCCNSH

CANCELLATIONS SUBSTITUTION
Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event.IMPORTANT NOTE:
Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407.

Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled.


DATA PROTECTION
The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (Database) on winnie.seah@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408.

剩余（BE）正常值为-3～+3mmol/L；21、代谢性酸中毒的最基本特征？答：代谢性酸中毒最基本的特征是血浆HCO3—浓度原发性减少，血浆SB、AB、BB均降低，BE负值增大

结合紫杉醇 100 mg/m2 QW+卡铂 AUC 6 Q3W（nab-PC）或紫杉醇 200 mg/m2+卡铂 AUC 6 Q3W（sb-PC）治疗，首要研究

（SB）、实际碳酸氢根（AB）、动脉血氧饱和度（SaO2）和阴离子隙（AG）等。急性循环衰竭（休克）患者常见代谢性酸中毒及低氧血症。创伤性休克中碱剩余

心动过缓 (SB 和 AV 传导阻滞 ) 的典型症状  

～+3mmol/L；21、代谢性酸中毒的最基本特征？答：代谢性酸中毒最基本的特征是血浆HCO3—浓度原发性减少，血浆SB、AB、BB均降低，BE负值增大，在失代偿时pH

急性胰腺炎（acute pancreatitis，AP）可分为间质水肿型及坏死型，其中后者可引起诸多并发症，并存在一定的死亡率，与死亡率相关的因素包括脏器衰竭及胰腺脓肿（infected pancreatic necrosis，IPN）。 AP早期患者主要死于脏器衰竭，称之为重型胰腺炎或爆发性胰腺炎，晚期死亡的主要

）（即 S2TOP-BLEED 评分模型，见表1）。表 1 预测严重出血的S2TOP-BLEED 评分（来自多变量 Cox 回归模型）具体评分方法为，根据患者临床特征评估 S2TOP-BLEED 评分列表中每一栏分值，除了年龄相关的项目外，将其他所有项目分值想加得总分，再将总分代入图 1 所示风险分布图中，得到不同

明，使用远程医疗工具，如电话，互动视频和共享电子病历进行的多学科PTSD非现场干预，即创伤后应激障碍远程医疗服务（TOP）与常规护理（UC）相比，治疗效果显著提升...包括了2009年11月至2011年9月份在CBOCs接受治疗的265名主要生活在农村的退伍军人。所有患者均符合PTSD诊断标准，他们被随机分配接受TOP治疗（N